Differences in dopaminergic neuroprotective effects of estrogen during estrous cycle
- 1 January 2003
- journal article
- research article
- Published by Wolters Kluwer Health in NeuroReport
- Vol. 14 (1) , 47-50
- https://doi.org/10.1097/00001756-200301200-00009
Abstract
Previous studies suggest that estrogen treatment protects nigrostriatal dopaminergic neurons, but have not examined whether the changes in estrogen levels during estrous cycle can influence the susceptibility of these neurons to neurotoxins. Here we show that the loss of dopaminergic neurons in the substantia nigra was greater in animals lesioned at diestrus (low estrogen) using 6-hydroxydopamine or buffered iron chloride, when compared with animals lesioned at proestrus (high estrogen). Lesioning at diestrus with 6-hydroxydopamine reduced the striatal dopamine content, whereas the dopamine content was preserved in animals lesioned at proestrus. The density of the dopamine transporter, upon which 6-hydroxydopamine toxicity is dependent, was lower when circulating estrogen was high. These results thus support a neuroprotectory role for estrogen.Keywords
This publication has 27 references indexed in Scilit:
- Estrogen use among nursing home residents with a diagnosis of Parkinson's diseaseMovement Disorders, 2000
- Neuroprotective effects of estrogen upon the nigrostriatal dopaminergic systemJournal of Neurocytology, 2000
- [ 11 C]RTI‐32 PET studies of the dopamine transporter in early dopa‐naive Parkinson's diseaseNeurology, 1997
- The absolute number of nerve cells in substantia nigra in normal subjects and in patients with Parkinson's disease estimated with an unbiased stereological method.Journal of Neurology, Neurosurgery & Psychiatry, 1991
- Estrogens and the Pathophysiology of Parkinson's DiseaseInternational Journal of Neuroscience, 1989
- The influence of estrogen on nigrostriatal dopamine activityBehavioural Brain Research, 1986
- Menstrual‐related fluctuations in Parkinson's diseaseMovement Disorders, 1986
- Estrogen treatment increases the oral component of apomorphine-induced stereotypyEuropean Journal of Pharmacology, 1984
- Modulation of apomorphine-induced stereotypy by estrogen: Time course and dose responseBrain Research Bulletin, 1980
- Time course of nigrostriatal degeneration in parkinson's diseaseJournal Of Neural Transmission-Parkinsons Disease and Dementia Section, 1976